Skip to main content

Biolase, Inc

BIOLDelisted Sep 6, 2024
Industry
Dental Equipment & Supplies
SEC CIK
0000811240

Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Biolase, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Biolase, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Biolase, Inc
NameTitleLast reported holdingLast filingFilings, past year
Lord Jonathan T MDDirector59,925Jun 12, 20230
Roper JessDirector0Jun 12, 20230
Summerhays Carol Gomez DDSDirector–Jun 12, 20230
Somerman Martha J. DDS, PhDDirector–Jun 12, 20230
OLoughlin Kathleen TDirector–Jun 12, 20230
Yale Kenneth P.Director–Jun 12, 20230
Beaver John RPresident & CEO0Jun 6, 20230
Sandor StevenChief Operating Officer–Jun 6, 20230
Bright JenniferChief Financial Officer–Jun 6, 20230
Schuler Education Foundation10% Owner5,522,223May 26, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 26, 2023 (view filing)1:13 PM ETFeb 11, 20201,200 daysLateSchuler Education Foundation10% OwnerPPurchase+1.31M$0.61+$797.8K+13.6%10.9M after
May 26, 2023 (view filing)1:13 PM ETJun 8-Dec 18, 20201,082 daysLateSchuler Education Foundation10% OwnerSSale−9.16M$0.4517−$4.14M−62.4%5.52M after10 lots
Dec 8, 2022 (view filing)Dec 71 dayLord Jonathan T MDDirectorSSale−3.54K$0.75−$2.65K−5.6%59.9K after
Dec 16, 2021 (view filing)6:38 PM ETDec 151 dayLord Jonathan T MDDirectorSSale−11.0K$0.38−$4.19K−1.7%633.1K after
Dec 2, 2021 (view filing)5:27 PM ETNov 302 daysBeaver John RPresident & CEOPPurchase+70.0K$0.45+$31.5K+12.7%621.5K after
Aug 23, 2021 (view filing)Aug 203 daysBeaver John RPresident & CEOPPurchase+35.0K$0.61+$21.4K+6.8%551.5K after